Hainan Poly Pharm. Co., Ltd (SHE:300630)
China flag China · Delayed Price · Currency is CNY
2.490
0.00 (0.00%)
Mar 21, 2025, 3:04 PM CST

Hainan Poly Pharm. Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
Sep '24 Dec '23 Dec '22 Jan '22 Dec '20 Dec '19 2014 - 2018
Operating Revenue
1,2581,2561,6041,4941,155893.76
Upgrade
Other Revenue
48.2148.2114.9114.733.1456.33
Upgrade
Revenue
1,3071,3041,6191,5091,189950.1
Upgrade
Revenue Growth (YoY)
49.91%-19.43%7.31%26.94%25.10%52.28%
Upgrade
Cost of Revenue
365.19351.51563.98428.85300.03174.76
Upgrade
Gross Profit
941.39952.971,0551,080888.57775.33
Upgrade
Selling, General & Admin
718.47616.36457.49314.87235.72254.94
Upgrade
Research & Development
181.26267.67263.04229.32191.18184.29
Upgrade
Other Operating Expenses
72.1413.0412.6317.8710.278.16
Upgrade
Operating Expenses
987.88925.17758.64562.06451.31458.14
Upgrade
Operating Income
-46.4827.8296.51517.92437.26317.19
Upgrade
Interest Expense
-69.56-54.36-40.15-55.71-7.42-3.45
Upgrade
Interest & Investment Income
21.899.134.9311.851.20.33
Upgrade
Currency Exchange Gain (Loss)
2.592.594.49-0.49-6.4-0.85
Upgrade
Other Non Operating Income (Expenses)
-10.1-0.27-1.21-15.34-0.170.38
Upgrade
EBT Excluding Unusual Items
-101.66-15.11264.57458.23424.47313.61
Upgrade
Gain (Loss) on Sale of Investments
---1.5-3.550.29-2.1
Upgrade
Gain (Loss) on Sale of Assets
-0.5--0.02--0.31
Upgrade
Asset Writedown
-18.19-15.770-0.010.01-0.01
Upgrade
Other Unusual Items
130.52105.7125.3812.8529.4722.98
Upgrade
Pretax Income
10.1674.82288.45467.54454.24334.16
Upgrade
Income Tax Expense
116.2-11.1-6.5150.9446.7933.01
Upgrade
Net Income
-106.0485.92294.96416.6407.45301.15
Upgrade
Net Income to Common
-106.0485.92294.96416.6407.45301.15
Upgrade
Net Income Growth
--70.87%-29.20%2.25%35.30%65.99%
Upgrade
Shares Outstanding (Basic)
434434434439438424
Upgrade
Shares Outstanding (Diluted)
434460468439438424
Upgrade
Shares Change (YoY)
-1.37%-1.67%6.76%0.09%3.29%0.71%
Upgrade
EPS (Basic)
-0.240.200.680.950.930.71
Upgrade
EPS (Diluted)
-0.240.190.630.950.930.71
Upgrade
EPS Growth
--69.84%-33.68%2.15%30.99%64.81%
Upgrade
Free Cash Flow
-322.41-435.43-808.72-646.74-504.46-187.14
Upgrade
Free Cash Flow Per Share
-0.74-0.95-1.73-1.48-1.15-0.44
Upgrade
Dividend Per Share
--0.0790.1920.1870.139
Upgrade
Dividend Growth
---59.07%2.57%34.63%51.97%
Upgrade
Gross Margin
72.05%73.05%65.17%71.58%74.76%81.61%
Upgrade
Operating Margin
-3.56%2.13%18.31%34.33%36.79%33.38%
Upgrade
Profit Margin
-8.12%6.59%18.22%27.61%34.28%31.70%
Upgrade
Free Cash Flow Margin
-24.68%-33.38%-49.95%-42.86%-42.44%-19.70%
Upgrade
EBITDA
165.6196.57407.53592.68493.68355.12
Upgrade
EBITDA Margin
12.67%15.07%25.17%39.28%41.53%37.38%
Upgrade
D&A For EBITDA
212.08168.77111.0274.7756.4237.93
Upgrade
EBIT
-46.4827.8296.51517.92437.26317.19
Upgrade
EBIT Margin
-3.56%2.13%18.31%34.33%36.79%33.38%
Upgrade
Effective Tax Rate
1143.31%--10.90%10.30%9.88%
Upgrade
Revenue as Reported
1,3071,3041,6191,5091,189950.1
Upgrade
Updated Oct 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.